Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Intec battered as Novartis ducks out of Accordion collaboration

Intec battered as Novartis ducks out of Accordion collaboration

Analyst Michael Higgins of Ladenburg Thalman said it was unclear whether Novartis’ drug failed in development or the competitive market dynamics changed. ... Ladenburg Thalman has previously estimated that the Novartis deal could be worth $30m to $80m

J&J splashes $750m on anti-inflammatory drug bermekimab

J&J splashes $750m on anti-inflammatory drug bermekimab The therapy is a follow-up to its older blockbuster Stelara, which is facing competition across many of its approved uses from newer biologic therapies – including Novartis’ IL-17 inhibtor Consentyx

Bluebird bio’s sickle cell gene therapy shows early-study benefit

Bluebird bio’s sickle cell gene therapy shows early-study benefit The FDA also cleared Novartis’ anti-P-selectin antibody Adakveo (crizanlizumab) to reduce VOCs – one of the most serious complications of SCD.

Armed with new data, BMS plans filings for Celgene CAR-T liso-cel

Armed with new data, BMS plans filings for Celgene CAR-T liso-cel third-to-market competitor to Novartis’  Kymriah(tisagenlecleucel) and Gilead Sciences  Yescarta (axicabtagene ciloleucel).

Novartis strengthens case for its combination asthma drug

Novartis strengthens case for its combination asthma drug Demonstrated significant benefits in uncontrolled asthma patients. Novartis has unveiled positive phase 3 data for its dual combination asthma drug QMF149, strengthening its case for approval with regulators. . ... According to Novartis, the safety

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics